NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $170,154 | -2.3% | 23,502 | +0.3% | 0.00% | – |
Q2 2023 | $174,091 | +25.6% | 23,431 | +17.1% | 0.00% | – |
Q1 2023 | $138,662 | -38.3% | 20,009 | -8.5% | 0.00% | – |
Q4 2022 | $224,772 | -31.1% | 21,865 | +22.0% | 0.00% | – |
Q3 2022 | $326,000 | -67.2% | 17,923 | -7.2% | 0.00% | -100.0% |
Q2 2022 | $994,000 | -24.1% | 19,319 | +8.6% | 0.00% | 0.0% |
Q1 2022 | $1,310,000 | -51.4% | 17,789 | -5.5% | 0.00% | -50.0% |
Q4 2021 | $2,694,000 | -72.1% | 18,834 | -59.6% | 0.00% | -66.7% |
Q3 2021 | $9,671,000 | +85.0% | 46,649 | +89.5% | 0.01% | +100.0% |
Q2 2021 | $5,227,000 | +31.8% | 24,616 | +12.6% | 0.00% | 0.0% |
Q1 2021 | $3,965,000 | +80.3% | 21,871 | +10.9% | 0.00% | +50.0% |
Q4 2020 | $2,199,000 | +33.5% | 19,723 | +29.8% | 0.00% | +100.0% |
Q3 2020 | $1,647,000 | +16.1% | 15,196 | -10.8% | 0.00% | 0.0% |
Q2 2020 | $1,419,000 | – | 17,028 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 50,910 | $5,516,000 | 10.50% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 297,400 | $32,223,000 | 4.94% |
Ikarian Capital, LLC | 375,400 | $40,675,000 | 2.94% |
TSP Capital Management Group, LLC | 60,075 | $6,509,000 | 2.66% |
RA Capital Management | 1,198,602 | $129,869,000 | 2.38% |
Foresite Capital Management I, LLC | 66,810 | $7,239,000 | 2.04% |
Healthcare Value Capital, LLC | 5,000 | $542,000 | 1.79% |
Rock Springs Capital Management LP | 585,705 | $63,461,000 | 1.61% |
Foresite Capital Management II, LLC | 67,373 | $7,300,000 | 1.59% |
BERYLSON CAPITAL PARTNERS, LLC | 30,104 | $3,262,000 | 1.14% |